Avid Bioservices expects new contractual commitments in the coming weeks and months after raising more than $20m and completing its transition to a dedicated CDMO, says CEO.
Impax Laboratories has sold its CorePharma facilities and equipment to a group of industry investors which aim to reestablish the company as a "preferred partner of choice," says new CEO.
DNAnexus has secured $58m financing, including a strategic investment from Microsoft, in order to further develop its translational medicine solutions.
Valeant, Rentschler, Celgene, MannKind, and Syngene are among those welcoming new leaders for 2016. Oh, and Turing waves goodbye to Martin Shkreli… welcome to a New Year’s CEO special.
Industry headhunters have picked their top CEOs in European pharma, saying the most successful investors keep chief execs in place even through hard times.
Kaare Schultz, Novo Nordisk Chief Operating Officer and planned successor as Chief Executive, resigned unexpectedly today. Plus FDA's ex-top scientist heads up US Pharmacopoeia.
Pharma services firm Peakdale Molecular has joined with two UK environmental testing providers to form Concept Life Sciences in a private-equity backed agreement.
In-Pharmatechnologist.com presents its latest round-up of the movers and shakers in the world of pharmaceuticals, in a rather global edition including news from Israel, Bangladesh and Australia.
Covance management sounded relatively upbeat about its expectations for 2013 as late-stage clinical trials continue to grow and IT spending begins to taper off, company officials said on Friday.
This week, in-PharmaTechnologist brings you its weekly round-up of the latest changes on the pharmaceutical job ladder from Interphex in New York. We present news from exhibitors Aesica and Patheon, as well as AstraZeneca, Array and Elsevier.
Outsourcing-Pharma presents its round-up of the latest career changes within the pharmaceutical industry, including news from Quintiles, Dell and CytomX.
Japanese drugmaker, Kyowa Hakko Kirin, has further expanded its presence in foreign markets after agreeing a deal to buy Scottish drug firm, ProStrakan.
eClinical company etrials saw losses increase in the fourth quarter of 2008, but pointed to a healthy increase in orders as evidence of the underlying strength of the business.
Genzyme will launch the same biologic under two different names in the US after the FDA decided the drug produced at 2000L was considerably different to the 160L version.
Outsourcing-Pharma.com presents its periodic round-up of personnel changes in the pharmaceutical outsourcing arena, with senior appointments at Bristol-Myers Squibb, Parexel and GVK Bio, amongst others.
Tongjitang Chinese Medicines, which produces traditional
treatments, has stopped manufacturing operations at its facility in
Guiyang, Guizhou province due to damage caused by the recent
earthquake.
Pfizer's announcement of plans to create a new €130m inhaled
medicines unit at its facility in Amboise, France suggests that the
firm is still intent on investing in inhalation technology, despite
its disappointment with Exubera.
Paladin Labs has reached an agreement in principle to acquire the
outstanding shares of BioEnvelop Inc, which develops, manufactures
and markets rapidly dissolving edible films for use as delivery
systems in the pharmaceutical and...
Dyax announced that it has reached a mutual agreement with Genzyme
to terminate their joint venture for the development and
commercialization of DX-88 for hereditary angioedema (HAE).
Fresh from Thermo's $10.4bn (€8.3bn) acquisition of the scientific
equipment and instrument specialists, Fisher Scientific posted
strong third quarter results that showed a profit rise of 62 per
cent coupled with an 11 per cent...
Thermo Electron has reported an operating profit growth of 26 per
cent to $143.2m (€111.2m) and boosted its profit margin by three
percentage points to 20 per cent in its second quarter results.
Galapagos are to acquire the drug discovery service operations of
Discovery Partners International for $6.4m in a move that cements
Galapagos' BioFocus division as a top three provider in drug
discovery services worldwide.
Alcan has acquired the outstanding minority share of Propack in a
deal that further cements the company's standing in the Chinese
market. The acquisition forms part of a major restructuring
exercise, in which the closure and...
The GEA Group has completed an agreement to acquire Steris's freeze
dryer (lyophiliser) product line, in a deal that aims to strengthen
the group's Process Engineering Division in the Process Engineering
Segment.
Galapagos has announced that its acquisition of BioFocus' would
accelerate its transition to a fully integrated drug development
biopharmaceutical company after the two companies reached agreement
on the terms of a recommended...
Novartis has announced the formation of a collaboration with Anadys
Pharmaceuticals to develop Hepatitis C (HCV) and hepatitis B (HBV)
therapeutics in a deal worth at least $570 million (€466 million).
UK-based Stanelco has acquired Biotec, a company based in Germany
that makes starch-based polymer packaging for the pharmaceutical
and food industries.
Ampac Packaging is continuing its acquisitive spree into 2005 with
the purchase of Flexicon, a maker of flexible packaging materials
for the pharmaceutical, medical and other industries.
Busy times for personnel in the pharmaceutical technology sector,
with a series of new appointments at the senior level in
ingredients, separation and drug delivery companies.
German biotech company Evotec OAI posted decreased third quarterly
revenues of €16.1 million, down 26 per cent compared to 2003.
Evotec's performance reflects the difficult operating environment
for companies supplying drug discovery...
Novel approaches to administering drugs took a step forward after
Aradigm announced positive trial results in its Intraject
needle-free delivery system, which paves the way for a viable
alternative to the standard needle injection.
Antibody technology company MorphoSys has formed a marketing
collaboration with Genefrontier, with a view to accessing the
Japanese life science market. This agreement will aim to establish
MorphoSys' HuCAL technology in the...
Two UK packaging machinery engineers, Autowrappers and Europack,
have been bought by Bradman Lake to create a packaging company that
can supply a full range of machinery and compete with the big
players in the pharmaceutical and food...
Pressure on pharma ingredient supplier Lonza has continued into the
first half of the year, with consistently low use of custom
manufacturing capacity and weak demand for biomanufacturing
contributing to a 37 per cent drop in operating...
Ireland's Elan has signed its first major contract manufacturing
and supply agreement in a development that reinforces its
credentials as a player in the outsourcing sector.
Tecan second-quarter results reveal some signs of recovery after a
torrid first quarter and the departure of former chief executive
Emile Sutcliffe, with diagnostics holding back an improved
performance in biopharma.